title: Analysis of events associated with serum deprivation-induced apoptosis in C3H/Sol8 muscle satellite cells.
abstract: Satellite cells are the source of new muscle fibers in postnatal skeletal muscle growth and regeneration. Regulation of satellite cell survival is of fundamental importance in maintaining normal muscle function. Here we describe and characterize a tissue culture model of satellite cell apoptosis. Kinetic studies indicate that serum deprivation triggers a set of sequential events: early cell death, transient cell cycle traverse, and delayed cell death. The satellite cell death occurs by apoptosis based on the internucleosomal DNA laddering, in situ DNA end-labeling, and the requirements for de novo protein synthesis and extracellular calcium influx. The transient period of cell cycle progression (7-11 h after serum withdrawal) is accompanied by temporal induction of members of the immediate early gene family, such as c-myc, c-fos, and SRF, and appears to precede the delayed phase of cell death. Satellite cell apoptosis can be suppressed by several growth factors and by blocking the activity of calpain, a calcium-regulated protease. The late phase of apoptosis is marked by selective activation of ubiquitin-mediated protein conjugation and degradation. This study defines several control points where satellite cell apoptosis may be genetically or pharmacologically intervened.
authors.affiliation: Department of Biochemistry, State University of New York at Buffalo 14214, USA.
authors.forename: L J
authors.initials: LJ
authors.lastname: Mampuru
authors.forename: S J
authors.initials: SJ
authors.lastname: Chen
authors.forename: J L
authors.initials: JL
authors.lastname: Kalenik
authors.forename: M E
authors.initials: ME
authors.lastname: Bradley
authors.forename: T C
authors.initials: TC
authors.lastname: Lee
mesh_terms: D000818:Animals; D017209:Apoptosis / Q000502:physiology*; D001790:Blood Physiological Phenomena; D002135:Calcium-Binding Proteins / Q000494:pharmacology; D002154:Calpain / Q000037:antagonists & inhibitors; D002453:Cell Cycle / Q000502:physiology; D002454:Cell Differentiation; D002455:Cell Division; D002460:Cell Line; D004247:DNA / Q000032:analysis; D004268:DNA-Binding Proteins / Q000032:analysis; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005786:Gene Expression Regulation; D017781:Genes, Immediate-Early / Q000235:genetics; D006133:Growth Substances / Q000502:physiology*; D007770:L-Lactate Dehydrogenase / Q000378:metabolism; D051379:Mice; D008809:Mice, Inbred C3H; D009124:Muscle Proteins / Q000096:biosynthesis; D018482:Muscle, Skeletal / Q000737:chemistry / Q000166:cytology* / Q000502:physiology; D009687:Nuclear Proteins / Q000032:analysis; D016760:Proto-Oncogene Proteins c-fos / Q000032:analysis; D016271:Proto-Oncogene Proteins c-myc / Q000032:analysis; D012333:RNA, Messenger / Q000032:analysis; D026362:Serum Response Factor; D014452:Ubiquitins / Q000032:analysis / Q000235:genetics
chemical_list: D002135:Calcium-Binding Proteins; D004268:DNA-Binding Proteins; D004791:Enzyme Inhibitors; D006133:Growth Substances; D009124:Muscle Proteins; D009687:Nuclear Proteins; D016760:Proto-Oncogene Proteins c-fos; D016271:Proto-Oncogene Proteins c-myc; D012333:RNA, Messenger; D026362:Serum Response Factor; D014452:Ubiquitins; C033668:calpastatin; D004247:DNA; D007770:L-Lactate Dehydrogenase; D002154:Calpain